Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC/EACTS Guidelines 2025 for VHD Address Patient Values
Author(s): Benoit Mores Added: 3 months ago

Anticoagulation
Systematic Scoping on DOACS in NVAF Patients
Author(s): Shirley Siang Ning Tan , Wei Hong Lai , Lee Len Tiong , et al Added: 6 months ago

Anticoagulation

Electrophysiology & Arrhythmia
Revascularisation in Patients with Cancer
Author(s): Miguel Nobre Menezes , Mamas A Mamas Added: 2 weeks ago

CV Disease in Special Populations

Intervention
ADA 25: PATHWEIGH: Weight Management in Primary Care
Author(s): Leigh Perreault Added: 7 months ago
ADA 25 - PATHWEIGH roadmap for implementing weight management into primary care eliminated a population weight gain trajectory.Dr Leigh Perreault (University of Colorado Anschutz Medical Campus, US) joins us remotely to discuss the PATHWEIGH trial, which investigated a process of care to facilitate and prioritize weight management in a primary care setting. PATHWEIGH focused on reducing excess… View more

Cardiovascular Renal Metabolic
Treatment Options and Continuity of Care in MAFLD
Author(s): Carmen Lara-Romero , Manuel Romero-Gómez Added: 1 year ago

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Implementing Heart Failure Guidelines with Collaborative Care
Start date: Aug 27, 2023 End date: Aug 27, 2023
Radcliffe Medical Education present a satellite symposium entitled ‘Implementing Heart Failure Guidelines with Collaborative Care’ at the ESC Congress 2023 in Amsterdam, NL. Join us in the Riga Lecture Room, or online, on Sunday 27 August 2023, from 12:45 to 13:45 CEST. This session, chaired by Prof Carolyn Lam (National Heart Centre Singapore, SG), provides an excellent opportunity for… View more

Heart Failure
Targeted Lipid Control in Very-high-risk Indian Patients: Expert Insights
Author(s): Kausik Ray , Upendra Kaul , Srinivasa Rao , et al Added: 1 month ago

Guidelines & Statements
AHA 25: Beta-Blocker Therapy Post MI in Patients with Preserved LVEF
Author(s): Anna Meta Dyrvig Kristensen Added: 2 months ago
AHA Scientific Sessions 2025 – Dr Anna Meta Dyrvig Kristensen (Copenhagen University Hospital, Bispebjerg and Frederiksberg, DK) presents an individual patient data meta-analysis examining beta-blocker therapy after myocardial infarction in patients with preserved left ventricular ejection fraction.This comprehensive meta-analysis pooled individual patient data from five randomized controlled… View more

Heart Failure
Complex Cases: TAVI and SAVR Outcomes in Patients with Bicuspid Aortic Stenosis with Prof Ole De Backer
Author(s): Ole De Backer Added: 6 months ago
Explore the challenges and outcomes of TAVI in bicuspid aortic stenosis with Prof Ole De Backer (Rigshospitalet, Copenhagen, Denmark).This presentation, part of a comprehensive two-part series on complex cases in interventional cardiology, examines the unique anatomical considerations and clinical evidence when treating bicuspid valve disease with transcatheter techniques.Prof De Backer addresses… View more

Intervention
ADA 25: MariTide Treatment for Obesity in Patients with or without T2D
Author(s): Harold Bays Added: 7 months ago
ADA 2025 - Once-monthly MariTide treatment demonstrates around 15% average weight reduction at 52 weeks in patients with obesity, with or without type 2 diabetes.We are joined by Dr Harold Bays (L-MARC Research Center, Louisville, US) to discuss a 52-week, placebo-controlled, phase 2 randomised study (NCT05669599) investigating the efficacy, safety and tolerability of different doses of once… View more

Cardiovascular Renal Metabolic